期刊文献+

乳腺浸润性导管癌伴广泛导管内癌成分对保乳术后局部复发的影响 被引量:5

Effect of breast invasive ductal carcinoma with extensive intraductal components on local recurrence after breast conserving surgery
原文传递
导出
摘要 目的 分析乳腺浸润性导管癌伴广泛导管内癌成分(extensive intraductal components,EIC)患者临床病理特征及预后因素.方法 回顾性分析我院接受保乳手术的182例早期乳腺浸润性导管癌患者的临床资料,比较EIC阳性(n=23)和EIC阴性(n=159)两组乳腺癌患者的临床病理特征及预后.结果 在EIC阳性组,同侧乳腺内局部复发率为21.7% (5/23),远处转移率为4.3%(1/23);在EIC阴性组,同侧乳腺局部复发率为1.9% (3/159),远处转移率为3.8% (6/159).EIC阳性组的5年无局部复发率低于EIC阴性组(78.0%比97.7%,P<0.001),差异有统计学意义,而两组的5年无远处转移率相似(95.7%比96.2%,P=0.892),差异无统计学意义.COX多因素分析显示EIC是影响乳腺浸润性导管癌患者保乳手术后局部复发的独立危险因素.结论 广泛导管内癌成分会增加乳腺浸润性导管癌患者的乳腺内局部复发率. Objective To analyze the clinicopathological features and prognostic factors of patients with breast invasive ductal carcinoma with extensive intraductal components (EIC).Methods The clinical data of 182 patients of early breast invasive ductal carcinoma undergoing breast-conserving surgery were analyzed retrospectively in the Second Affiliated Hospital of Soochow University,and the clinicopathological features and prognosis of two groups of breast cancer patients with EIC positive (n =23) and EIC negative (n =159) were compared.Results In the EIC positive group,ipsilateral breast tumor recurrence (IBTR) was 21.7% (5/23) and the distant metastasis rate was 4.3% (1/23);in the EIC negative group,ipsilateral breast tumor recurrence (IBTR) was 1.9% (3/159) and the distant metastasis rate was 3.8% (6/159).The Kaplan-Meier curve showed that the 5-year local recurrence-free survival rates in the EIC positive group was lower than that of the EIC negative group (78% vs.97.7%) (P < 0.001),and the difference was statistically significant,but the 5-year distant metastasis-free survival rates in the two groups was similar (95.7% vs.96.2%) (P =0.892).COX multivariate analysis showed that EIC was an independent risk factor for local recurrence after breast-conserving surgery in breast invasive ductal carcinoma patients.Conclusions EIC increases the local recurrence rate in patients with breast invasive ductal carcinoma undergoing breast-conserving surgery.
作者 梅玉新 周雅 邹汉青 殷瑞 黄蕾 吴恩昊 汤光圆 朱旬 Mei Yuxin;Zhou Ya;Zou Hanqing;Yin Rui;Huang Lei;Wu Enhao;Tang Guangyuan;Zhu Xun(Department of General Surgery,the Second Affiliated Hospital of Soochow University,Suzhou 215004,China)
出处 《中华普通外科杂志》 CSCD 北大核心 2019年第4期340-344,共5页 Chinese Journal of General Surgery
关键词 乳腺肿瘤 预后 保乳手术 广泛导管内癌成分 Breast neoplasms Prognosis Breast-conserving surgery Extensive intraductal component
  • 相关文献

参考文献3

二级参考文献35

  • 1汪敏.早期乳腺癌保乳手术及改良根治术的临床疗效及生活质量的比较[J].实用癌症杂志,2014,29(3):321-323. 被引量:56
  • 2Osteen RT,Connolly JL,Recht A,et al.Identification of patients at high risk of local recurrence after conservative surgery and radiation therapy for stage Ⅰ or Ⅱ breast cancer[J].Arch Surg,1987,122 (11):1248-1252.
  • 3Voogd AC,Nielsen M,Peterse JL,et al.Differences in risk factors for local and distant recurrence after breast-conserving therapy or mastectomy for stage Ⅰ and Ⅱ breast cancer:pooled results of two large European randomized trials[J].J Clin Onco1,2001,19(6):1688-1697.
  • 4Zhao H,Morimoto T,Sasa M,et al.Immunohistochemical expression of uPA,PAI-1,cathepsin D and apoptotic cells in ductal carcinoma in situ of the breast[J].Breast Cancer,2002,9 (2):118-126.
  • 5Leong C,Boyages J,Jayasinghe UW,et al.Effect of margins on ipsilateral breast tumor recurrence after breast conservation therapy for lymph node-negative breast carcinoma[J].Cancer,2004,100(9):1823-1832.
  • 6Smitt MC.Selection criteria for accelerated partial-breast irradiation:impact on applicability[J].Clin Breast Cancer,2004,5(4):308 -312.
  • 7Kute TE,Russell GB,Zbieranski N,et al.Prognostic markers in node-negative breast cancer:a prospective study[J].Cytometry B Clin Cytom,2004,59 (1):24 -31.
  • 8Isola J,Weitz S,Visakorpi T,et al.Cathepsin D expression detected by immunohistochemistry has independent prognostic value in axillary node-negative breast cancer[J].J Clin Oncol,1993,11(1):36 -43.
  • 9Watanabe E,Toyoda M,Okuda J,et al.Detection of apoptotic cells in human colorectal cancer by two different in situ methods:antibody against single-stranded DNA and terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end-labeling (TUNEL) methods[J].Jpn J Cancer Res,1999,90:188-193.
  • 10Voogd AC, Nielsen M, Peterse JL, et al. Differences in risk factors for local and distant recurrence after breast-conserving therapy or mastectomy for stage I and Ⅱ breast cancer: pooled results of two large European randomized trials. J Clin Oncol , 2001,19:1688-1697.

共引文献29

同被引文献41

引证文献5

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部